Panagora Asset Management Inc Clovis Oncology, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $361,761 - $1.7 Million	-574,225 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.43 - $3.14 $25,740 - $56,520	18,000 Added 3.24%	574,225 $1.16 Million
Q4 2021 Feb 10, 2022	BUY	$2.7 - $4.76 $205,972 - $363,121	76,286 Added 15.89%	556,225 $1.51 Million
Q3 2021 Nov 10, 2021	BUY	$4.06 - $5.8 $173,443 - $247,776	42,720 Added 9.77%	479,939 $2.14 Million
Q2 2021 Aug 11, 2021	SELL	$5.02 - $7.05 $95,500 - $134,119	-19,024 Reduced 4.17%	437,219 $2.54 Million
Q1 2021 May 12, 2021	SELL	$4.81 - $10.34 $75,459 - $162,213	-15,688 Reduced 3.32%	456,243 $3.2 Million
Q4 2020 Feb 10, 2021	BUY	$4.13 - $6.41 $445,705 - $691,760	107,919 Added 29.65%	471,931 $2.27 Million
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $425,152 - $680,950	88,206 Added 31.98%	364,012 $2.12 Million
Q2 2020 Aug 12, 2020	BUY	$5.69 - $9.69 $1.29 Million - $2.2 Million	227,375 Added 469.48%	275,806 $1.86 Million
Q1 2020 May 14, 2020	SELL	$3.77 - $11.0 $16,972 - $49,522	-4,502 Reduced 8.51%	48,431 $308,000
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $783,285 - $4.29 Million	-261,095 Reduced 83.14%	52,933 $552,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $1.13 Million - $4.42 Million	288,064 Added 1109.47%	314,028 $1.23 Million
Q2 2019 Aug 09, 2019	BUY	$12.81 - $25.67 $331,266 - $663,826	25,860 Added 24865.38%	25,964 $386,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $22,841 - $64,163	-1,964 Reduced 94.97%	104 $2,000
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $510,973 - $690,405	-10,195 Reduced 83.14%	2,068 $109,000
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $34,383 - $50,409	-596 Reduced 4.63%	12,263 $834,000
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $863,739 - $1.09 Million	12,859	12,859 $1.06 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account